Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Dudley Robert E., Chief Executive Officer. Officer active across 1 company, notably Clarus Therapeutics Holdings, Inc.. Aggregated, 4 filings have been published. Activity tracked since 9 September 2021. The latest transaction was filed on 12 December 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Robert E. Dudley is the Chief Executive Officer of Clarus Therapeutics Holdings, Inc. In this role, he oversees the company's operations and is responsible for the overall strategy. With expertise in the pharmaceutical sector, he is committed to developing innovative solutions and maximizing shareholder value.